Publicacións (171) Publicacións nas que participase algún/ha investigador/a

2024

  1. 18F-FDG positron emission tomography as a marker of disease activity and treatment response in ankylosing spondylitis and psoriatic arthritis

    Scientific Reports, Vol. 14, Núm. 1

  2. 2-Aryladenine Derivatives as a Potent Scaffold for Adenosine Receptor Antagonists: The 6-Morpholino Derivatives

    Molecules, Vol. 29, Núm. 11

  3. A cohort analysis of familial partial lipodystrophy from two Mediterranean countries

    Diabetes, Obesity and Metabolism, Vol. 26, Núm. 11, pp. 4875-4886

  4. A foundation for comparative genomics and evolutionary studies in Nucella lapillus based on complete mitogenome assembly

    Marine Biology, Vol. 171, Núm. 5

  5. A genome-wide association meta-analysis of all-cause and vascular dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 9, pp. 5973-5995

  6. A genome-wide association study meta-analysis in a European sample of stage III/IV grade C periodontitis patients ≤35 years of age identifies new risk loci

    Journal of Clinical Periodontology, Vol. 51, Núm. 4, pp. 431-440

  7. A journey through the history of PEGylated drug delivery nanocarriers

    Drug Delivery and Translational Research, Vol. 14, Núm. 8, pp. 2026-2031

  8. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma

    Frontiers in Immunology, Vol. 15

  9. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology

  10. AB067. New drug development for the use of PARP1-E2F1 transcriptional inhibitors in the treatment of glioblastoma

    Chinese clinical oncology, Vol. 13, pp. AB067

  11. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  12. Aggregation-resistant alpha-synuclein tetramers are reduced in the blood of Parkinson’s patients

    EMBO Molecular Medicine, Vol. 16, Núm. 7, pp. 1657-1674

  13. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population

    Cancer Chemotherapy and Pharmacology, Vol. 94, Núm. 3, pp. 387-395

  14. Altered dynamics of calcium fluxes and mitochondrial metabolism in platelet activation-related disease and aging

    Life Sciences, Vol. 351

  15. Alternative translation initiation by ribosomal leaky scanning produces multiple isoforms of the Pif1 helicase

    Nucleic Acids Research, Vol. 52, Núm. 12, pp. 6928-6944

  16. An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

    Journal of Alzheimer's Disease, Vol. 98, Núm. 2, pp. 601-618

  17. Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

    npj Parkinson's Disease, Vol. 10, Núm. 1

  18. Antiobesity effects of intestinal gluconeogenesis are mediated by the brown adipose tissue sympathetic nervous system

    Obesity, Vol. 32, Núm. 4, pp. 710-722

  19. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  20. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)

    Vaccines, Vol. 12, Núm. 1